NCT07123480 (MOST-CR) is a NA clinical trial of Usual Care Group in Ethics, sponsored by Baystate Medical Center.

Who is sponsoring NCT07123480?

NCT07123480 is sponsored by Baystate Medical Center.

What drugs are being tested in NCT07123480?

Interventions in NCT07123480: Usual Care Group, More Support and Tools.

What condition does NCT07123480 study?

NCT07123480 studies Ethics, Cardiac Rehabilitation, Coronary Heart Disease (CHD), Heart Failure, Percutaneous Coronary Intervention (PCI), Aortic Valve Replacement, Myocardial Infarction (MI).

Is NCT07123480 still recruiting?

NCT07123480 is currently active, enrolled. Last updated 26 November 2025.

Last reviewed 2025-11-26 · How we verify

NCT07123480: MOST-CR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Role of 4 Different Consent Approaches on a Pilot Study to Increase Cardiac Rehabilitation Attendance

Active, enrolled NA Last updated 26 November 2025

What this trial tests

NA trial testing Usual Care Group in Ethics in 160 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

16 July 2025

Primary endpoint
31 January 2026

30 June 2026

Quick facts

Lead sponsor	Baystate Medical Center
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	health services research
Enrollment	160
Start date	16 July 2025
Primary completion	31 January 2026
Estimated completion	30 June 2026
Sites	1 location across United States

Drugs / interventions tested

Usual Care Group — full drug profile →
More Support and Tools

Conditions studied

Ethics — all drugs for Ethics →
Cardiac Rehabilitation — all drugs for Cardiac Rehabilitation →
Coronary Heart Disease (CHD) — all drugs for Coronary Heart Disease (CHD) →
Heart Failure — all drugs for Heart Failure →

Sponsor

Baystate Medical Center

Who can join

18 and older, any sex, with Ethics or Cardiac Rehabilitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cardiac Rehabilitation is a lifestyle and exercise program for patients with heart disease. Cardiac Rehabilitation is strongly recommended in guidelines, but only 30% of eligible patients attend. New strategies are needed to help more patients attend cardiac rehabilitation. In this study, the investigators will see if using an $50 incentive, case management, text messages, and physical activity coaching combined into a single intervention will help more patients attend cardiac rehabilitation. In preparation for a larger trial, patients will also be randomly assigned to four different ways of seeking their permission to be in a research study. The investigators will see if these approaches affect how many people participate in the research project. The two main goals of this study is to understand: 1. If the consent approach type impacts participation rates in the research study 2. If the multi-component intervention (case management, financial incentives, text messages, and physical activity coaching) improves cardiac rehabilitation participation within 3 months.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Usual Care Group

Trials testing the same drug.

NCT07327450 — Coaching Doctors and Nurses to Improve Ethical Decision-making in Team · NA · not yet recruiting
NCT07452055 — Large Language Model-Based Emotional Management for Breast Cancer Patients · NA · not yet recruiting
NCT07519603 — Frailty in Older Adults With Chronic Obstructive Pulmonary Disease (COPD) and Outcomes of the VIVIFRAIL Program · NA · recruiting
NCT07219251 — Engagement of Veterans With Lung Cancer · NA · recruiting
NCT07321158 — The Effectiveness of Different Pulse Duration of NMES in Patients With Pyramidal Tract-related Spasticity Measured by Ne · NA · recruiting

Other recruiting trials for Ethics

Currently open trials in the same condition.

NCT06759805 — Electronic Cardiac Rehabilitation (eCardiacRehab) Feasibility Study · NA · recruiting

Other Baystate Medical Center trials

Trials by the same sponsor.

NCT07168642 — A Type I Hybrid Effectiveness-Implementation Trial of MIO · NA · recruiting
NCT07168629 — A Community Health Worker Intervention to Improve Lung Cancer Screening Uptake in Community Health Centers · NA · not yet recruiting
NCT07019454 — Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysm · NA · recruiting
NCT06527820 — Aim 2 - Conversations Can Save Lives: TALKing About Buprenorphine & Methadone for Opioid Use Treatment Initiation · NA · recruiting
NCT05925634 — Improving Cardiac Rehabilitation Exercise Using Target Heart Rate Trial · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07123480 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Baystate Medical Center
Last refreshed: 26 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07123480.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing